JAGX
Jaguar Health, Inc.NASDAQHealthcare$0.40+2.52%ClosedMarket Cap: $869,754
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.11
P/S
0.08
EV/EBITDA
-0.71
DCF Value
$-2,806.09
FCF Yield
-2924.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
77.2%
Operating Margin
-278.5%
Net Margin
-341.9%
ROE
-710.6%
ROA
-81.4%
ROIC
-89.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $3.1M | 64.6% | $-7.2M | $-9.5M | $-6.28 | — |
| Q2 2025 | $3.0M | 82.3% | $-8.0M | $-10.4M | $-10.26 | — |
| Q1 2025 | $2.2M | 76.7% | $-9.4M | $-10.5M | $-16.70 | — |
| Q4 2024 | $3.5M | 84.1% | $-8.2M | $-9.9M | $-33.68 | — |
| FY 2024 | $11.7M | 83.3% | $-30.8M | $-38.5M | $-130.69 | — |
| Q3 2024 | $3.1M | 82.6% | $-7.3M | $-9.9M | $-26.25 | — |
| Q2 2024 | $2.7M | 84.3% | $-7.2M | $-9.5M | $-101.00 | — |
| Q1 2024 | $2.4M | 81.7% | $-8.2M | $-9.2M | $-5,220.00 | — |
| Q4 2023 | $2.3M | 70.1% | $-7.6M | $-9.2M | $-600.00 | — |
| FY 2023 | $9.8M | 79.1% | $-34.3M | $-41.3M | $-2,685.00 | — |
| Q3 2023 | $2.8M | 81.7% | $-8.8M | $-7.8M | $-570.00 | — |
| Q2 2023 | $2.7M | 81.7% | $-8.1M | $-12.2M | $-630.00 | — |